123,619 Shares in HCA Healthcare, Inc. $HCA Purchased by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 123,619 shares of the company’s stock, valued at approximately $48,198,000.

Several other hedge funds have also recently made changes to their positions in HCA. Sumitomo Life Insurance Co. grew its position in HCA Healthcare by 1.0% in the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares in the last quarter. MJP Associates Inc. ADV boosted its stake in HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC boosted its position in shares of HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares during the period. Anchyra Partners LLC grew its stake in shares of HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after buying an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd lifted its stake in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after acquiring an additional 22 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $419.19 on Friday. The business has a fifty day moving average price of $400.24 and a 200 day moving average price of $441.63. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The stock has a market capitalization of $90.75 billion, a P/E ratio of 14.03, a price-to-earnings-growth ratio of 1.48 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the company posted $6.84 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.45%.

Analyst Ratings Changes

Several analysts have recently weighed in on HCA shares. The Goldman Sachs Group decreased their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research report on Tuesday, July 28th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Cantor Fitzgerald dropped their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 price target on shares of HCA Healthcare in a research note on Monday, July 27th. Finally, Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.